03:58 AM EDT, 05/13/2025 (MT Newswires) -- Syndax Pharmaceuticals ( SNDX ) said Monday that it appointed Nicholas Botwood as chief medical officer and head of research and development.

Prior to this role, Botwood has been head of worldwide medical oncology at Bristol Myers Squibb ( BMY ) since 2022.

He will succeed Neil Gallagher who is departing to pursue other opportunities, the company said.